Coave Therapeutics
Cell & Gene Therapy · Health Care
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
Read more
Report
Coave Therapeutics Strengthens Leadership Team to Advance Lead Gene Therapy Program into the Clinic
Read more
Report
VP Platform Discovery
Reporting to the Chief Scientific Officer, the VP - Platform Operations will play a central role ensuring seamless execution of Coave's ALIGATER platform activities.
Read more
Report
Coave Therapeutics to unveil OneAAV universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors
Read more
Report
Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program
Read more
Report
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery
Read more
Report
Coave Therapeutics demonstrates superiority of its novel suprachoroidal capsidat ESGCT Congress 2025
Read more
Report
Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases
Read more
Report